These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17931140)

  • 41. Does over-the-counter nicotine replacement therapy improve smokers' life expectancy?
    Lawrence WF; Smith SS; Baker TB; Fiore MC
    Tob Control; 1998; 7(4):364-8. PubMed ID: 10093169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advising your client on nicotine replacement aids.
    Clark D
    Prof Care Mother Child; 1995; 5(3):72-4. PubMed ID: 8680229
    [No Abstract]   [Full Text] [Related]  

  • 43. Nicotine patches and uninsured quitline callers. A randomized trial of two versus eight weeks.
    McAfee TA; Bush T; Deprey TM; Mahoney LD; Zbikowski SM; Fellows JL; McClure JB
    Am J Prev Med; 2008 Aug; 35(2):103-10. PubMed ID: 18617079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial.
    Shiffman S; Ferguson SG; Strahs KR
    Am J Prev Med; 2009 Feb; 36(2):96-104.e1. PubMed ID: 19135903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacotherapy for tobacco dependence.
    Fant RV; Buchhalter AR; Buchman AC; Henningfield JE
    Handb Exp Pharmacol; 2009; (192):487-510. PubMed ID: 19184660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
    Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
    Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adverse effects with use of nicotine replacement therapy among quitline clients.
    Ossip DJ; Abrams SM; Mahoney MC; Sall D; Cummings KM
    Nicotine Tob Res; 2009 Apr; 11(4):408-17. PubMed ID: 19325134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health literacy characteristics of over-the-counter rapid antigen COVID-19 test materials.
    Fulmer AA; Abboud GA; Wallace LS
    Res Social Adm Pharm; 2022 Dec; 18(12):4124-4128. PubMed ID: 35987673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Citations to trials of nicotine replacement therapy were biased toward positive results and high-impact-factor journals.
    Etter JF; Stapleton J
    J Clin Epidemiol; 2009 Aug; 62(8):831-7. PubMed ID: 19128941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of nicotine replacement therapy on postoperative mortality following coronary artery bypass graft surgery.
    Paciullo CA; Short MR; Steinke DT; Jennings HR
    Ann Pharmacother; 2009 Jul; 43(7):1197-202. PubMed ID: 19567657
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of barriers that impede the implementation of nicotine replacement therapy in the acute cardiac care setting.
    May FC; Stocks N; Barton C
    Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):646-50. PubMed ID: 18779735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Readability and Content Characteristics of Powdered Infant Formula Instructions in the United States.
    Wallace LS; Rosenstein PF; Gal N
    Matern Child Health J; 2016 Apr; 20(4):889-94. PubMed ID: 26649882
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Update on pharmacologic options for smoking cessation treatment.
    Nides M
    Am J Med; 2008 Apr; 121(4 Suppl 1):S20-31. PubMed ID: 18342163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of quality and readability of over-the-counter medication package inserts.
    Zheng Y; Tang Y; Tseng HC; Chang TH; Li L; Chen P; Tang Y; Lin XB; Chen X; Tang KJ
    Res Social Adm Pharm; 2022 Sep; 18(9):3560-3567. PubMed ID: 35379561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Commentary] improving NRT labeling and correcting public misperceptions.
    Foulds J
    Addiction; 2008 Aug; 103(8):1379-80. PubMed ID: 18855828
    [No Abstract]   [Full Text] [Related]  

  • 56. [Potential risk of the consumption of non-prescription drugs in an elderly hypertensive subject on nicotine substitute therapy--case presentation].
    Rajska-Neumann A; Saran A; Wieczorowska-Tobis K
    Przegl Lek; 2004; 61(10):1172-3. PubMed ID: 15794281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers.
    Sun HQ; Guo S; Chen DF; Jiang ZN; Liu Y; Di XL; Yang FD; Zhang XY; Kosten TR; Lu L
    Am J Drug Alcohol Abuse; 2009; 35(3):183-8. PubMed ID: 19462302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Readability of patient information leaflets on over-the-counter (OTC) medicines.
    Bradley B; Singleton M; Li Wan Po A
    J Clin Pharm Ther; 1994 Feb; 19(1):7-15. PubMed ID: 8188795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nicotine dependence, psychological distress and personality traits as possible predictors of smoking cessation. Results of a double-blind study with nicotine patch.
    Cosci F; Corlando A; Fornai E; Pistelli F; Paoletti P; Carrozzi L
    Addict Behav; 2009 Jan; 34(1):28-35. PubMed ID: 18804918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
    Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK
    Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.